ADILW Stock Summary and Trading Ideas (Adial Pharmaceuticals - Warrant | NASDAQ:ADILW)

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Adial Pharmaceuticals - Warrant trades on the NASDAQ stock market under the symbol ADILW.

As of March 29, 2023, ADILW stock price was flat at $0.04 with 107 million shares trading.

ADILW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.

In the last 3 years, ADILW stock traded as high as $2.45 and as low as $.01.

ADILW has underperformed the market in the last year with a price return of -92.3% while the SPY ETF lost -10.6%. However, in the short term, ADILW had mixed performance relative to the market. It has outperformed in the last 3 months, returning +100.5% vs +7.0% return in SPY. But in the last 2 weeks, ADILW shares have been beat by the market, returning -50.6% compared to an SPY return of +2.8%.

ADILW support price is $.02 and resistance is $.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADILW stock will trade within this expected range on the day.